×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Friedman Mark Louis

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AXGNAxogen, Inc.Friedman Mark LouisVP Regulatory Affairs & PolicyMar 16, 2022Option Exercise$7.971,50211,97124,343Mar 18, 2022, 04:06 PM
AXGNAxogen, Inc.Friedman Mark LouisVP Regulatory Affairs & PolicyDec 27, 2021Option Exercise$9.742862,78617,452Dec 29, 2021, 04:23 PM
AXGNAxogen, Inc.Friedman Mark LouisVP Regulatory Affairs & PolicyDec 20, 2021Option Exercise$9.249587816,588Dec 22, 2021, 04:06 PM
AXGNAxogen, Inc.Friedman Mark LouisVP Regulatory Affairs & PolicyJul 20, 2021Option Exercise$19.2063712,23016,308Jul 21, 2021, 04:12 PM
AXGNAxogen, Inc.Friedman Mark LouisVP, Regulatory & QualityFeb 17, 2021Option Exercise$18.7095117,78713,936Feb 18, 2021, 05:26 PM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityDec 29, 2020Sale$17.8156710,09811,124Dec 30, 2020, 11:52 AM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityDec 21, 2020Sale$16.42961,5768,893Dec 22, 2020, 11:38 AM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityDec 03, 2020Option Exercise$3.863,81214,7038,614Dec 07, 2020, 02:39 PM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityFeb 18, 2020Option Exercise$14.6892413,5644,802Feb 20, 2020, 01:25 PM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityDec 18, 2019Option Exercise$16.731833,0622,127Dec 20, 2019, 04:27 PM
AXGNAxogen, Inc.Friedman Mark LouisVP,Regulatory & QualityMay 17, 2019Option Exercise$21.1467,9521,436,5941,560May 17, 2019, 09:47 PM
AXGNAxoGen, Inc.Friedman Mark LouisVP,Regulatory & QualityFeb 15, 2019Option Exercise$17.5757310,06869,512Feb 19, 2019, 01:25 PM
AXGNAxoGen, Inc.Friedman Mark LouisVP,Regulatory & QualityOct 24, 2017Option Exercise$3.8873,247284,56267,952Oct 26, 2017, 05:04 PM
AXGNAxoGen, Inc.Friedman Mark LouisVice President of RA/QADec 23, 2011Option Exercise$0.275,6651,5305,665Jan 24, 2012, 04:08 PM